Zeyuan Yang
Appearances
- DateMay 6, 2023BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
Presenter
Stanford University Hospital - DateMay 7, 2023Chronic hepatitis delta (CHD) typically leads to cirrhosis and hepatic decompensation. The only treatment option for CHD patients with decompensated cirrhosis is liver transplantation with associated short- and long-term complications…
Presenter
Speakers
- DateMay 18, 2024BACKGROUND: Adults with metabolic dysfunction associated steatotic liver disease (MASLD) have high risk of cardiovascular disease (CVD) and CVD-related mortality. However, it remains unclear whether adults with lean vs…
Presenter
Stanford University Hospital - DateMay 18, 2024BACKGROUND: The rising clinical burden of alcohol related liver disease in the U.S. has been exacerbated by COVID-19 pandemic-related increases in high-risk alcohol use…
Presenter